4//SEC Filing
Halladay Benjamin 4
Accession 0001104659-22-126269
CIK 0001434868other
Filed
Dec 11, 7:00 PM ET
Accepted
Dec 12, 4:07 PM ET
Size
7.5 KB
Accession
0001104659-22-126269
Insider Transaction Report
Form 4
Halladay Benjamin
Chief Financial Officer
Transactions
- Award
Common Stock
2022-12-09+44,000→ 63,771 total - Award
Stock Option (right to buy)
2022-12-09+66,000→ 66,000 totalExercise: $5.09Exp: 2032-12-09→ Common Stock (66,000 underlying)
Footnotes (2)
- [F1]Such award will vest over a four (4) year period as follows: 25% shall vest on the one year anniversary of December 15, 2022 and the remainder shall vest in equal quarterly installments over the three (3) year period thereafter, subject to continued service.
- [F2]Such options will vest over a four (4) year period as follows: 25% shall vest on the one year anniversary of December 15, 2022 and the remainder shall vest in equal quarterly installments over the three (3) year period thereafter, subject to continued service.
Documents
Issuer
Esperion Therapeutics, Inc.
CIK 0001434868
Entity typeother
Related Parties
1- filerCIK 0001953943
Filing Metadata
- Form type
- 4
- Filed
- Dec 11, 7:00 PM ET
- Accepted
- Dec 12, 4:07 PM ET
- Size
- 7.5 KB